Literature DB >> 26994418

Relationships between typical histopathological hallmarks and the ferritin in the hippocampus from patients with Alzheimer's disease.

Jolanta Kwiatek-Majkusiak1, Dennis W Dickson2, Paweł Tacik2, Naoya Aoki2, Ryszard Tomasiuk3, Dariusz Koziorowski4, Andrzej Friedman4.   

Abstract

Oxidative stress is one of the possible mechanisms of neurodegeneration. One of the elements of this mechanism are altered iron homeostasis and changes concerning of iron metabolism regulatory proteins. The primary iron storage protein in cells is ferritin, composed of heavy (H) and light (L) chains. In brain tissue neurons contain mainly ferritin H-chains, whereas glial cells are rich in L-chains. To the best of our knowledge, this is the first study that compares structure of ferritin and histopathological hallmarks in hippocampal tissue affected by the pathological process of Alzheimer's disease (AD). Our data indicate a statistically significant correlation between the concentration of L chains of ferritin, the H/L ratio and the amount of senile plaques in the subiculum, CA1 and CA4 sectors of the hippocampus (p<0.001, p=0.025, p=0.029). A significant correlation was also found between the concentration of L-ferritin and neuronal loss (p=0.0026). These findings indicate an important role of ferritin light chains in neurodegeneration, that is linked to chronic inflammation processes and the associated activation of the microglia rich of L chains.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26994418

Source DB:  PubMed          Journal:  Acta Neurobiol Exp (Wars)        ISSN: 0065-1400            Impact factor:   1.579


  9 in total

Review 1.  [Neuroinflammation as motor of Alzheimer's disease].

Authors:  Sergio Castro-Gomez; Julius Binder; Michael T Heneka
Journal:  Nervenarzt       Date:  2019-09       Impact factor: 1.214

Review 2.  Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Current Evidence and Future Perspectives.

Authors:  Donovan A McGrowder; Fabian Miller; Kurt Vaz; Chukwuemeka Nwokocha; Cameil Wilson-Clarke; Melisa Anderson-Cross; Jabari Brown; Lennox Anderson-Jackson; Lowen Williams; Lyndon Latore; Rory Thompson; Ruby Alexander-Lindo
Journal:  Brain Sci       Date:  2021-02-10

Review 3.  Treating Alzheimer's disease by targeting iron.

Authors:  Sara Nikseresht; Ashley I Bush; Scott Ayton
Journal:  Br J Pharmacol       Date:  2019-02-11       Impact factor: 8.739

4.  Markers of microglia in post-mortem brain samples from patients with Alzheimer's disease: a systematic review.

Authors:  K E Hopperton; D Mohammad; M O Trépanier; V Giuliano; R P Bazinet
Journal:  Mol Psychiatry       Date:  2017-12-12       Impact factor: 15.992

5.  Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin.

Authors:  Douglas G Walker; Lih-Fen Lue; Thomas G Beach; Ikuo Tooyama
Journal:  Cells       Date:  2019-07-23       Impact factor: 6.600

6.  Hepcidin overexpression in astrocytes alters brain iron metabolism and protects against amyloid-β induced brain damage in mice.

Authors:  Xinwei Zhang; Yu-Jing Gou; Yating Zhang; Jie Li; Kang Han; Yong Xu; Haiyan Li; Lin-Hao You; Peng Yu; Yan-Zhong Chang; Guofen Gao
Journal:  Cell Death Discov       Date:  2020-10-30

Review 7.  Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer's Disease.

Authors:  Zhiwei Shen; Xinjie Bao; Renzhi Wang
Journal:  Front Aging Neurosci       Date:  2018-10-08       Impact factor: 5.750

Review 8.  Current understanding of metal ions in the pathogenesis of Alzheimer's disease.

Authors:  Lu Wang; Ya-Ling Yin; Xin-Zi Liu; Peng Shen; Yan-Ge Zheng; Xin-Rui Lan; Cheng-Biao Lu; Jian-Zhi Wang
Journal:  Transl Neurodegener       Date:  2020-04-03       Impact factor: 8.014

9.  B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment.

Authors:  Hieronim Jakubowski; Anetta Zioła-Frankowska; Marcin Frankowski; Joanna Perła-Kaján; Helga Refsum; Celeste A de Jager; A David Smith
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.